Finally, we confirmed an increase in the levels of miR-196a-5p in LSC-enriched CD34+CD38−CD26+ fraction by reverse transcription followed by quantitative PCR (RT-qPCR) in additional CML-CP patients. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.